HOME >> MEDICINE >> NEWS
Passive smoking at work increases rate of sick leave among employees

Workers forced to breathe in their colleagues' cigarette smoke are significantly more likely to take sick leave and require medical attention, shows a study in the Journal of Epidemiology and Community Health.

A health survey of all officers in the Hong Kong Police force showed that the longer officers were exposed to passive smoking, the more time they took off work, the more visits they made to a doctor for respiratory complaints, and the more likely they were to take medicines. The total sample survey comprised almost 10,000 officers, all of whom were healthy, just over half of whom had never smoked; 14 percent of these were women.

Non-smoking men exposed to passive smoking at work for more than a year were twice as likely to take time off and over 30 per cent more likely to have required treatment for respiratory symptoms in the preceding 14 days than their colleagues working in a smoke-free environment. The results held true even after accounting for levels of passive smoking at home.

Trends among women were similar but the numbers were too small to show significant results.

The Environmental Protection Agency estimates that a universal ban on workplace smoking in the United States would save up to $72 billion. There are many work environments throughout the world where employees are forced to passively smoke, to say nothing of the public places, say the authors. Workplace smoking should be banned, they conclude.


'"/>

Contact: Dr. Sarah McGhee
smmcghee@hkucc.hku.hk
852-2819-9193
Center for the Advancement of Health
20-Aug-2000


Page: 1

Related medicine news :

1. Passive smoking in childhood may increase risk of lung cancer in later life
2. Passive tobacco smoke increases complications in children with sickle cell disease
3. Passive smoking increases the risk of heart disease
4. Controversy Over The Effects Of Passive Smoking
5. UB Oral Biologists Find Link Between Gum Disease And Passive Exposure To Tobacco Smoke
6. NHS stop-smoking services are insufficient to deliver national smoking targets
7. Study suggests smoking while pregnant may increase chromosomal abnormalities in fetal cells
8. Current daily smoking may be associated with increased risk for suicidal thoughts and attempts
9. School-based smoking prevention programs ineffective
10. Parents who quit smoking may influence their offspring to quit as young adults
11. Inpatient smoking cessation counseling is associated with early differences in mortality

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Passive smoking work increases rate sick leave among employees

(Date:7/30/2015)... ... 30, 2015 , ... Zaca Life has created Recovery Chewable ... water needed, the refreshing berry-flavored tablets are the perfect travel companion. , “We ... that may help with body detoxification, protection and hydration,” said Mark Aleks, Zaca ...
(Date:7/30/2015)... ... July 30, 2015 , ... The American Telemedicine Association (ATA) ... Tradeshow focused exclusively on telemedicine, telehealth and mHealth. The meeting, expected to attract ... take place May 14-17, 2016 in Minneapolis, MN. , ATA’s annual meeting attracts ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... Orange, Riverside, Los Angeles, and San Bernardino counties, today announced that Dr. Michael ... Care Administrator. Dr. Demoratz is a strong proponent of early access to palliative ...
(Date:7/30/2015)... ... 2015 , ... The Beryl Institute announces its sixth annual ... Patient Experience Institute, these offerings reinforce the commitment to help frame and expand ... the experience movement, and provide information and research to support expanded focus and ...
(Date:7/30/2015)... ... July 30, 2015 , ... The Mesothelioma Applied Research ... Patient Registry Act of 2015’. The bill was introduced in Congress yesterday by ... Betty McCollum (D-MN), Joe Kennedy (D-MA), and Leonard Lance (R-NJ). The purpose of ...
Breaking Medicine News(10 mins):Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 2Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 3Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 4Health News:Presentation Proposals for ATA 2016 are Now Being Accepted Online at ATA2016.com 2Health News:Presentation Proposals for ATA 2016 are Now Being Accepted Online at ATA2016.com 3Health News:24/7 Care At Home Welcomes Michael Demoratz, PhD, LCSW, CCM as New Palliative Care Administrator 2Health News:24/7 Care At Home Welcomes Michael Demoratz, PhD, LCSW, CCM as New Palliative Care Administrator 3Health News:The Beryl Institute Opens Applications for 2015 Patient Experience Grant and Scholar Programs 2Health News:The Beryl Institute Opens Applications for 2015 Patient Experience Grant and Scholar Programs 3Health News:Bill to Create Patient Registry for Deadly Cancer Introduced in Congress 2
(Date:7/29/2015)... July 30, 2015 Roche (SIX: RO, ROG; ... cobas® EGFR Mutation Test v2 for Premarket Approval ... (FDA), as a companion diagnostic test for AZD9291, ... cancer patients with an acquired resistant mutation.  ... who have adenocarcinoma with tumor containing an EGFR ...
(Date:7/29/2015)... 2015  Unilife Corporation ("Unilife" or the "Company") (NASDAQ: ... and supplier of injectable drug delivery systems, today announced ... the Company with flexibility and control to support its ... an equity purchase agreement for up to $45 million ... Chicago -based institutional investor, which provides the ...
(Date:7/29/2015)... BERKELEY, Calif. , July 29, 2015 /PRNewswire/ ... of the Daiichi Sankyo Group, announced today that ... clinical trial results demonstrating that the investigational drug, PLX3397, ... in most patients with tenosynovial giant cell tumor (TGCT), ... tendon sheath. Following phase 1 dose-escalation, which ...
Breaking Medicine Technology:Roche submits filing to FDA for companion diagnostic for non-small cell lung cancer drug therapy 2Roche submits filing to FDA for companion diagnostic for non-small cell lung cancer drug therapy 3Unilife Announces Multifaceted Financing Strategy 2Unilife Announces Multifaceted Financing Strategy 3Unilife Announces Multifaceted Financing Strategy 4Unilife Announces Multifaceted Financing Strategy 5Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 2Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 3Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 4Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 5
Cached News: